Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel ® Ofteno PF

Conditions: Dry Eye Disease; Ocular Surface Disease Interventions: Drug: PRO-229; Drug: Lagricel ® Ofteno PF Sponsors: Laboratorios Sophia S.A de C.V. Not yet recruiting

https://clinicaltrials.gov/study/NCT06370585

Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

More News: Opthalmology | Research | Study